|
⚲
|
| Keyboard |
| Burkavage Brian
✚
|
|
|---|---|
| CIK # | 0001865633 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001865633] | |
| 4 | [0001865633] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Damora Therapeutics Inc | |
| Burkavage Brian | |
| IO Biotech Inc | |
| Passage Bio Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
IO Biotech Inc IOBT
Stock Option (Right to Buy) · derivative
|
2025-04-02 | Grant | 65,000 | $0.00 | |
|
IO Biotech Inc IOBT
Stock Option (Right to Buy) · derivative
|
2024-03-15 | Grant | 50,000 | $0.00 | |
|
IO Biotech Inc IOBT
Common Stock
|
2023-11-22 | Buy | 5,000 | $1.04 | 5,200 |
|
IO Biotech Inc IOBT
Common Stock
|
2023-11-21 | Buy | 5,000 | $0.99 | 4,950 |
|
IO Biotech Inc IOBT
Stock Option (Right to Buy) · derivative
|
2023-03-20 | Grant | 50,000 | $0.00 | |
|
IO Biotech Inc IOBT
Stock Option (Right to Buy) · derivative
|
2022-05-31 | Grant | 20,000 | $0.00 |